News

We are proud to introduce our top-grade disposable EDTA K2 and K3 vacuum blood collection tubes, designed to meet the highest standards of clinical diagnostics and laboratory testing. As a trusted manufacturer of medical consumables with 23 years experiences...

With cases of diabetes rising significantly over the past 18 years, Chinese medical experts are urging people to adopt healthier lifestyles. A recent study found that 233 million people in China had diabetes as of 2023, a 163 percent increase from 2005....

Plain Tubes (No Additives Tubes), Serum Tubes( Clot Activator Tubes), and SST Tubes (Serum Separator Tubes) are three types of vacuum blood collection tubes that are used to obtain serum specimens for laboratory testing. While they share the common purpose...

We are pleased to announce the successful completion and on-time shipment of a significant bulk order tailored to the specific requirements of our valued customer in Malaysia. This order included our three kinds of blood collection tubes, they are EDTA K2 PET...

Recently, the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences published a groundbreaking research result in Nature Nanotechnology. The magnetic nanorobot system developed by them has for the first time achieved a full-chain treatment of "crossing the blood-brain barrier - precise navigation - targeted blasting", bringing a revolutionary solution to brain diseases such as Alzheimer's disease.

Washington, June 12, 2024 - The U.S. Food and Drug Administration (FDA) today accelerated the approval of the gene therapy "SOD1-ASO" (brand name Toferson) developed by Swiss pharmaceutical giant Novartis for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene. This is the world's first gene therapy drug targeting a specific subtype of ALS.

The latest research shows that long-term lack of sleep not only leads to fatigue and memory decline, but also may increase the risk of Alzheimer's disease. Scientists have found that during sleep, the brain initiates a "cleaning mode" to remove harmful proteins, and staying up late disrupts this process, accelerating cognitive decline.

The latest report from the WHO warns that the crisis of antibiotic resistance is accelerating. If not dealt with urgently, it may cause the death of tens of millions of people worldwide in the next decade, threatening the foundation of the modern medical system.

EU approves breakthrough Alzheimer's drug donanemab, shown to slow cognitive decline by 35%, but its $30,000 annual cost raises accessibility concerns for patients worldwide.